Search research articles
Contact Us
Filters
Showing results (121-130 of 297) with videos related to
Page
of 30
Sort By:
Cancer Immunology, Immunotherapy : CII
|
August 29, 2014
Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction
Marie-Cristine Kuehnle, Sebastian Attig, Cedrik M Britten, et al.
Clinical Lung Cancer
|
July 5, 2014
Assessment of folate receptor-α and epidermal growth factor receptor expression in pemetrexed-treated non-small-cell lung cancer patients
Daniel C Christoph, Bernadette Reyna-Asuncion, Biftu Hassan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 5, 2024
Comprehensive biomarker diagnostics of unfavorable cancer of unknown primary to identify patients eligible for precision medical therapies
Gregor Zaun, Sabrina Borchert, Martin Metzenmacher, et al.
Endocrine-Related Cancer
|
September 2, 2021
Antitumor immune response is associated with favorable survival in GEP-NEN G3
Vivian Rosery, Henning Reis, Konstantinos Savvatakis, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
August 6, 2025
Exploration of Fully-Automated Body Composition Analysis Using Routine CT-Staging of Lung Cancer Patients for Survival Prognosis
Marc-David Künnemann, Christian Römer, Anne Helfen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 3, 2013
Symptom control and quality of life in LUX-Lung 3: a phase III study of afatinib or cisplatin/pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutations
James Chih-Hsin Yang, Vera Hirsh, Martin Schuler, et al.
Clinical EEG and Neuroscience
|
October 21, 2024
Neurofeedback Reduces P300 Amplitudes to Intensely Emotive Pictures in Depressed Cancer Patients
Marvin Krawutschke, Martin Teufel, Kira Schmidt, et al.
Cancer Immunology, Immunotherapy : CII
|
February 5, 2005
Subcutaneous injection of interleukin 12 induces systemic inflammatory responses in humans: implications for the use of IL-12 as vaccine adjuvant
Johanna E A Portielje, Wim H J Kruit, Anke J M Eerenberg, et al.
Scientific Reports
|
June 14, 2024
C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy
Cedric Richlitzki, Marcel Wiesweg, Martin Metzenmacher, et al.
Oncology Research and Treatment
|
January 9, 2023
A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO)
Isabel Virchow, Jürgen-Walter Treckmann, Nicole Prasnikar, et al.
Page
of 30
Search research articles
Search
Showing results (121-130 of 297) with videos related to
Sort By:
Page
of 30
Cancer Immunology, Immunotherapy : CII
|
August 29, 2014
Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction
Marie-Cristine Kuehnle, Sebastian Attig, Cedrik M Britten, et al.
Clinical Lung Cancer
|
July 5, 2014
Assessment of folate receptor-α and epidermal growth factor receptor expression in pemetrexed-treated non-small-cell lung cancer patients
Daniel C Christoph, Bernadette Reyna-Asuncion, Biftu Hassan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 5, 2024
Comprehensive biomarker diagnostics of unfavorable cancer of unknown primary to identify patients eligible for precision medical therapies
Gregor Zaun, Sabrina Borchert, Martin Metzenmacher, et al.
Endocrine-Related Cancer
|
September 2, 2021
Antitumor immune response is associated with favorable survival in GEP-NEN G3
Vivian Rosery, Henning Reis, Konstantinos Savvatakis, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
August 6, 2025
Exploration of Fully-Automated Body Composition Analysis Using Routine CT-Staging of Lung Cancer Patients for Survival Prognosis
Marc-David Künnemann, Christian Römer, Anne Helfen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 3, 2013
Symptom control and quality of life in LUX-Lung 3: a phase III study of afatinib or cisplatin/pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutations
James Chih-Hsin Yang, Vera Hirsh, Martin Schuler, et al.
Clinical EEG and Neuroscience
|
October 21, 2024
Neurofeedback Reduces P300 Amplitudes to Intensely Emotive Pictures in Depressed Cancer Patients
Marvin Krawutschke, Martin Teufel, Kira Schmidt, et al.
Cancer Immunology, Immunotherapy : CII
|
February 5, 2005
Subcutaneous injection of interleukin 12 induces systemic inflammatory responses in humans: implications for the use of IL-12 as vaccine adjuvant
Johanna E A Portielje, Wim H J Kruit, Anke J M Eerenberg, et al.
Scientific Reports
|
June 14, 2024
C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy
Cedric Richlitzki, Marcel Wiesweg, Martin Metzenmacher, et al.
Oncology Research and Treatment
|
January 9, 2023
A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO)
Isabel Virchow, Jürgen-Walter Treckmann, Nicole Prasnikar, et al.
Page
of 30